发明名称 Use of oritavancin for prevention and treatment of anthrax
摘要 Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.
申请公布号 US9089507(B2) 申请公布日期 2015.07.28
申请号 US200712442751 申请日期 2007.09.24
申请人 THE MEDICINES COMPANY 发明人 Moeck Gregory;Parr, Jr. Thomas Reeves
分类号 A61K38/14;A61K31/00;A61K31/7052 主分类号 A61K38/14
代理机构 Roylance, Abrams, Berdo & Goodman, L.L.P. 代理人 Roylance, Abrams, Berdo & Goodman, L.L.P.
主权项 1. A method of preventing a B. anthracis infection in a subject, consisting of administering to a subject at risk of exposure to B. anthracis one or more antibiotics in an amount sufficient to prevent B. anthracis infection, wherein the one or more antibiotics includes oritavancin, or a pharmaceutically acceptable salt, or hydrate thereof, or a mixture thereof, thereby preventing a B. anthracis infection in a subject.
地址 Parsippany NJ US